It has been officially confirmed that Proteus Clinical Lead, Kev Dhaliwal, has been promoted to the position of Professor at the University of Edinburgh.
Kev is Professor of Molecular Imaging and Healthcare Technology, and a Consultant Physician in Respiratory Medicine.
He subspecialises in pulmonary infection and tuberculosis, and is currently performing translational research in collaboration with the Intensive Care Unit (ICU) developing and applying non-invasive methodologies for imaging inflammation. Kev is the Chief Investigator of 6 ‘first in human’ trials of optical molecular imaging reagents and devices. He collaborates widely with industry and is passionate about translating physical sciences into healthcare.
With a BSc in Medical Microbiology and a PhD in Optical Molecular Imaging and Lung Inflammation, Kev has been working closely with Professor Mark Bradley and Professor Chris Haslett for the past 10 years to develop a lung focused molecular imaging strategy – the same strategy behind the existence of Proteus.
Congratulations to Kev on this phenomenal achievement! The whole Proteus team are very proud of you.